Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2014
12/02/2014US8901301 Pyrrolo[2,3-]pyridine kinase inhibitors
12/02/2014US8901297 Compositions for modulating a kinase cascade and methods of use thereof
12/02/2014US8901293 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
12/02/2014US8901246 Method for preparing branched functionalized polymers using branched polyol cores
12/02/2014US8901177 Method of treating bladder disorders
12/02/2014US8901176 Methods for treatment of Parkinson's disease
12/02/2014US8901175 Use of opioids or opioid mimetics for the treatment of resistant cancer patients
12/02/2014US8901174 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
12/02/2014US8901173 Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
12/02/2014US8901172 Method for treating an inflammation or lesion caused by a virus
12/02/2014US8901171 Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent
12/02/2014US8901170 Malononitrile compounds
12/02/2014US8901169 Neprilysin inhibitors
12/02/2014US8901168 Vitamin E supplementation to tetanus toxoid
12/02/2014US8901167 Product and process for inhibition of biofilm development
12/02/2014US8901166 Epigallocatechin gallate tetramer and vascular endothelial function improving agent containing the same
12/02/2014US8901164 Amphipathic and other double-sided alpha-helix mimetics based on a 1,2-diphenylacetylene scaffold
12/02/2014US8901163 Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
12/02/2014US8901162 Substituted imidazolium compounds for treating disease
12/02/2014US8901161 Therapeutic compositions comprising imidazole and imidazolium compounds
12/02/2014US8901159 Inhibition of inflammation by simultaneous blockade of multiple prostanoid receptors
12/02/2014US8901158 Treatment of bipolar disorder
12/02/2014US8901157 Compositions and methods of use of ritonavir for treating HCV
12/02/2014US8901156 Compounds and methods
12/02/2014US8901155 Method for treating a TRPV1-mediated disease
12/02/2014US8901154 High concentration topical insecticides containing pyrethroids
12/02/2014US8901152 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
12/02/2014US8901151 Preparation and therapeutic applications of (2S, 3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide
12/02/2014US8901150 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
12/02/2014US8901149 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
12/02/2014US8901148 Large substituent, non-phenolic opioids and methods of use thereof
12/02/2014US8901147 Bi-heteroaryl compounds as Vps34 inhibitors
12/02/2014US8901146 Aminoalkylpyrimidine derivatives as histamine H4 receptor antagonists
12/02/2014US8901145 Aminopyrimidine kinase inhibitors
12/02/2014US8901144 Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
12/02/2014US8901143 Pyrimidine derivatives
12/02/2014US8901142 Fused tricyclic compounds as mTOR inhibitors
12/02/2014US8901141 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
12/02/2014US8901140 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
12/02/2014US8901139 Tricyclic indole derivatives and methods of use thereof
12/02/2014US8901138 Sulfoximine substituted quinazolines for pharmaceutical compositions
12/02/2014US8901137 Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K and mTOR in combination with autophagy inhibitors
12/02/2014US8901136 Heteroaryl compounds useful as inhibitors of E1 activating enzymes
12/02/2014US8901134 Pyrazolo [3,4-D] pyrimidine derivatives useful to treat respiratory disorders
12/02/2014US8901133 Heterocyclic compounds and uses thereof
12/02/2014US8901132 Thiazolopyrimidine modulators as immunosuppressive agents
12/02/2014US8901131 Gatifloxacin-containing ophthalmic gel and preparation method thereof
12/02/2014US8901130 Low hygroscopic aripiprazole drug substance and processes for the preparation
12/02/2014US8901129 Methods of facilitating neural cell survival using GDNF family ligand (GFL) mimetics or RET signaling pathway activators
12/02/2014US8901128 Pharmaceutical compositions of ranolazine
12/02/2014US8901126 Substituted imidazo[1,5-A]quinoxalin-4-ones are useful for preventing or treating storage dysfunction, voiding dysfunction and bladder/urethral diseases
12/02/2014US8901125 Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors
12/02/2014US8901124 Pyridazine amide compounds useful as SYK inhibitors
12/02/2014US8901123 Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
12/02/2014US8901122 Collagen stimulators and their use in the treatment of skin
12/02/2014US8901121 Metalloenzyme inhibitor compounds
12/02/2014US8901120 Substituted N-phenylpyrimidin-2-amine analogs as inhibitors of the Axl kinase
12/02/2014US8901119 Peptide deformylase inhibitors
12/02/2014US8901118 Compounds and methods for kinase modulation, and indications therefor
12/02/2014US8901117 Small molecule inhibitors of MDM2 and the uses thereof
12/02/2014US8901116 Method for treating pain, anxiety or depression using carbamoyloxy alkanoyl piperazine compound
12/02/2014US8901115 Cyclic P1 linkers as factor XIa inhibitors
12/02/2014US8901114 Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
12/02/2014US8901113 Methods and compositions for deterring abuse
12/02/2014US8901111 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
12/02/2014US8901110 Use of biomarkers in methods for the treatment of hepatocellular carcinoma
12/02/2014US8901109 Quercetin-containing compositions
12/02/2014US8901108 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists
12/02/2014US8901107 Lipid-lowering antidiabetic agent
12/02/2014US8901106 Imidazole prodrug LXR modulators
12/02/2014US8901105 Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
12/02/2014US8901104 Use of dextran sulfate
12/02/2014US8901103 Use of lipid conjugates in the treatment of diseases
12/02/2014US8901100 Tumor-specific delivery of therapeutic agents via liposomase
12/02/2014US8901098 Antisense modulation of GCCR expression
12/02/2014US8901094 Use of nucleic acid sequences for the treatment of epilepsy
12/02/2014US8901092 Functionalized polysaccharides for active agent delivery
12/02/2014US8901091 Method of treating herpes virus infection using macrocyclic lactone compound
12/02/2014US8901090 Method of treating otitis externa using macrocyclic lactone compound
12/02/2014US8901089 Composition comprising an amorphous non-crystalline glass form of roxithromycin
12/02/2014US8901087 Selective glycosidase inhibitors and uses thereof
12/02/2014US8901086 Compositions including triciribine and methods of use thereof
12/02/2014US8901082 Immunity-inducing agent and method for detection of cancer
12/02/2014US8901071 Compounds and their use
12/02/2014US8901038 Biphenyl-substituted cyclic ketoenols
12/02/2014US8900859 Cell homogenate from stem cells derived from growing deer antlers, a method of obtaining it and its use
12/02/2014US8900641 Antimicrobial composition
12/02/2014US8900638 Solid preparation comprising alogliptin and metformin hydrochloride
12/02/2014US8900637 Stable taste masked formulations of cephalosporins
12/02/2014US8900636 Controlled release compositions
12/02/2014US8900635 Nanoparticle isoflavone compositions and methods of making and using the same
12/02/2014US8900634 Diethylstilbestrol dosage form and methods of treatment using thereof
12/02/2014US8900632 Rapidly disintegrating coated tablets
12/02/2014US8900631 Dosage form to increase prasterone bioavailability
12/02/2014US8900626 Transdermal drug delivery system and method of using the same
12/02/2014US8900625 Antimicrobial compounds and methods of use
12/02/2014US8900622 Hypotensive lipid-containing biodegradable intraocular implants and related methods
12/02/2014US8900621 Polyamine derivatives
12/02/2014US8900617 Bio-Remodable Bone Augmentation device and method
12/02/2014US8900615 Drug delivery system
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 7860